River BioMedics develops novel, disease modifying small molecule therapies for cardiac diseases directly targeting the heart
River BioMedics develops novel, disease modifying small molecule therapies for cardiac diseases directly targeting the heart. By using unique human cardiac in vitro models for target and compound validation, they aim to create a human relevant drug pipeline.